-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PM/TdzTDs5o2EVzzEVF3675vqHhwG3IE9dUWhcgsasp1tLeylAZKOQzVuyO21Lw8 I9aWRRmJINg+0pzOdFkBSg== 0001104659-06-005803.txt : 20060203 0001104659-06-005803.hdr.sgml : 20060203 20060203122522 ACCESSION NUMBER: 0001104659-06-005803 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20060131 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20060203 DATE AS OF CHANGE: 20060203 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HEMACARE CORP /CA/ CENTRAL INDEX KEY: 0000801748 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 953280412 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-15223 FILM NUMBER: 06576511 BUSINESS ADDRESS: STREET 1: 21101 OXNARD STREET CITY: WOODLAND HILLS STATE: CA ZIP: 91367 BUSINESS PHONE: 818-226-1968 MAIL ADDRESS: STREET 1: 21101 OXNARD STREEET CITY: WOODLAND HILLS STATE: CA ZIP: 91367 8-K 1 a06-4207_18k.htm CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of the earliest event reported):  January 31, 2006

 

HEMACARE CORPORATION

(Exact name of registrant as specified in its charter)

 

California

 

000-15223

 

95-3280412

(State or other jurisdiction
of incorporation or organization)

 

(Commission
File Number)

 

(I.R.S. Employer
Identification No.)

 

21101 Oxnard Street, Woodland Hills, CA 91367
(Address of principal executive offices) (Zip Code)

 

(818) 226-1968

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 



 

Item 1.01.              Entry into a Material Definitive Agreement.

 

On January 31, 2006, HemaCare Corporation (the “Company”) entered into the third modification (the “Modification”) to the Loan and Security Agreement, dated November 19, 2002, as amended on March 22, 2004 and July 1, 2005, among the Company, Coral Blood Services, Inc. and Comerica Bank (the “Bank”).  The Modification provides for letters of credit to be issued by the Bank for the account of the Company in an amount not to exceed one million dollars.  As of September 30, 2005, the Company had no net borrowing on this line of credit and the Company had unused availability of $2,000,000.

 

The foregoing summary of the Modification is qualified in its entirety by the actual Modification attached hereto as Exhibit 99.1 and incorporated herein by reference.

 

Item 9.01.

Financial Statements and Exhibits

 

 

 

(c)

 

Exhibits

 

 

 

 

 

Exhibit No.

 

Description

 

 

99.1

 

Third Modification to Loan and Security Agreement among HemaCare Corporation, Coral Blood Services, Inc. and Comerica Bank, dated January 31, 2006

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 Date: February 3, 2006

HEMACARE CORPORATION

 

 

 

 

 

By

/s/ Robert S. Chilton

 

 

 

Robert S. Chilton,

 

 

Executive Vice President and Chief
Financial Officer

 

3



 

Exhibit Index

 

Exhibit No.

 

Description

99.1

 

Third Modification to Loan and Security Agreement among HemaCare Corporation, Coral Blood Services, Inc and Comerica Bank, dated January 31, 2006

 

4


EX-99.1 2 a06-4207_1ex99d1.htm EXHIBIT 99

Exhibit 99.1

 

 

THIRD MODIFICATION TO LOAN AND SECURITY AGREEMENT

 

This Third Modification to Loan and Security Agreement (this “Modification”) is entered into by and between HEMACARE CORPORATION and CORAL BLOOD SERVICES, INC. (“Borrower”) and COMERICA BANK (“Bank”) as of this 31st day of January, 2006, at San Jose, California.

 

RECITALS

 

This Modification is entered into upon the basis of the following facts and understandings of the parties, which facts and understandings are acknowledged by the parties to be true and accurate:

 

Bank and Borrower previously entered into a Loan and Security Agreement (Accounts and Inventory) dated November 19, 2002, which was subsequently modified pursuant to those certain modification agreements dated March 22, 2004 and July 1, 2005. The Loan and Security Agreement as so modified, and as such may be otherwise modified, amended, restated, supplemented, revised or replaced from time to time prior to the date hereof shall collectively be referred to herein as the “Agreement.”

 

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as set forth below.

 

AGREEMENT

 

1.             Incorporation  by Reference. The Recitals and the documents referred to therein are Incorporated herein by this reference. Except as otherwise noted, the terms not defined herein shall have the meaning set forth in the Agreement.

 

2.             Modification to the Agreement. Subject to the satisfaction of the conditions precedent as set forth in Section 3 hereof, the Agreement is hereby modified as set forth below.

 

a.             Section 2.3 of the Agreement is hereby deleted in its entirety and replaced with the following:

 

“2.3         Subject to the terms and conditions of this Agreement, Bank agrees to issue or cause to be issued letters of credit for the account of Borrower during the term of this Agreement in the aggregate outstanding face amount not to exceed (i) the lesser of the Credit Limit or the Borrowing Base, minus (ii) the then outstanding Daily Balance, provided that the Letter of Credit Obligations shall not in any case exceed One Million and no/100 Dollars ($1,000,000.00). All letters of credit shall be in form and substance, acceptable to Bank in its sole discretion and shall be subject to the terms and conditions of Bank’s form of standard Letter of Credit Application and Agreement.

 

The obligation of Borrower to immediately reimburse Bank for drawings made under letters of credit shall be absolute, unconditional and irrevocable in accordance with the terms of this Agreement and the Letter of Credit Application and Agreement with respect to each such letter of credit. Borrower shall indemnify, defend, protect and hold Bank harmless from any loss, cost, expense, or liability, including, without limitation, reasonable attorney’s fees incurred by Bank, whether in-house or outside counsel is used, arising out of or in connection with any letters of credit.”

 

3.             Legal Effect.

 

a.             Except as specifically set forth in this Modification, all of the terms and conditions of the Agreement remain in full force and effect. Except as expressly set forth herein, the execution, delivery, and performance of this Modification shall not operate as a waiver of, or as an amendment of, any right, power, or remedy of Bank under the Agreement, as in effect prior to the date hereof. Borrower ratifies and reaffirms the continuing effectiveness of all promissory notes, guaranties, security agreements, mortgages, deeds of trust, environmental agreements, and all other instruments, documents and agreements entered into in connection with the Agreement.

 

b.             Borrower represents and warrants that each of the representations and warranties contained in the Agreement are true and correct as of the date of this Modification, and that no Event of Default has occurred and is continuing.

 

c.             The effectiveness of this Modification and each of the documents, instruments and agreements entered into in connection with this Modification is conditioned upon receipt by Bank of this Modification and any other documents which Bank may require to carry out the terms.

 

4.             Miscellaneous Provisions.

 

a.             This is an integrated Modification and supersedes all prior negotiations and agreements regarding the subject matter hereof. All amendments hereto must be in writing and signed by the parties.

 

1



 

b.             This Modification may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one instrument.

 

IN WITNESS WHEREOF, the parties have agreed as of the date first set forth above.

 

HEMACARE CORPORATION

COMERICA BANK

By:

/s/ Judi Irving

 

By :

/s/ Geoff Mathews

 

Title:

CEO

 

 

Geoff Mathews

 

 

 

Title:

Assistant Vice President-Western Division

By:

/s/ Robert S. Chilton

 

 

Title:

EVP & CFO

 

 

 

 

CORAL BLOOD SERVICES, INC.

 

 

 

By:

/s/ Judi Irving

 

 

Title:

CEO

 

 

 

 

 

 

By:

/s/ Robert S. Chilton

 

 

Title:

EVP & CFO

 

 

 

2


GRAPHIC 3 g42071mmi001.jpg GRAPHIC begin 644 g42071mmi001.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T- M#AT5%A$8(Q\E)"(?(B$F*S7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBI MJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W M^/GZ_]H`"`$!```_`/9:********************R?$VKCP[X9O]450[V\1: M-&.0TAX4'GH6(&!^%>/ZI\4=3T75[JQEU74=0G@.[Z7-K$L2N0`8[9R!@8)*V_ M4\\8XXY-03_%_P`11#RVN-2BE`R?,>U[\CC[,.Q'\_:KZ_%IS`C-XDU])2%W MQC3K)E7IN`;`W8YP<#/MGB>/XN0HM2)\9;11@ZMK+\DY.F6WKTXD[=*7_A6T*,^7T!S^_ M'?)XSQ^MFU^*%U>7L-M9^*K9[B4HD27FC&*%W8XPSK*Q7GJ<8Y^N/3?#.L_V M]X?M-19`DTBE9XUZ)*I*NHY/`8''MBM6BBBBBO/_`(K:M;VUKI6FR1O(TMPU MZX7'^JMU,C#J.3P!^/IS\Z,Q9BS$DDY)/>BNE\=3R#6+?3%=OL6G65O':QG: M`JM"CLWR\$LS%B>IR,],"_J&JW0T[P]K,*P7UW=Y2]61!-Y[Q$1I'*,Y(,:H M=O!)8MU(QOV=EI^GW6G6\&E6+1GQ9+IY::!)B\!V*4W,/F'S-@GGZ^>3GL,4+.=-3\2Z?87WALVT MO]M6^_S(52.$,RJT+1+&HVL`IP?0G^)B9Q+;7ESXMTZ;1M+B_LVUO'@DAM-C MHQN(QWYXR0N1E1P,#BJVI07 MRZM8RCYI&BU-'S][[0@>10,#[LFX9]3CC%>@T44445Y'\8(@^NVXF(MEETR6 M*VNY0/*$N\$H20<$H&4>[CH,UY1'X>$EF+M=:TD1DL`K7)5_E4L?D(W=%... M3@#)(!O?\(-<_P#0?\.?^#>'_&MJXTN\U#3[2UU+4/"EY)8PB"VG?6$5UC!R M$;:XW`+M&6.UD\VW1=@Z8JII?ACQ/IVC:KI3Z787$&I)&&W:G;`QNA)1P=_49/'<$UE?\` M"N_$W_/K:?\`@RMO_CE'_"N_$W_/K:?^#*V_^.5Z-\+X);+Q196DF);VVTF: MWOA%,LB0KYX>(EU)#,02NT'@`>A`]?HHHHHIDD4%`Y?_ M`(1K24>.,]L8[_`.<5IV6GV6F6XMK"S@M(`21%!&(UR>IP!BK%%%%1 47*326[I;S"&5AA9"F_;[XR,U_]D_ ` end
-----END PRIVACY-ENHANCED MESSAGE-----